- Home
- RVYL vs KLTO Comparison
RVYL vs KLTO Comparison
Compare RVYL & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVYL
- KLTO
- Stock Information
- Founded
- RVYL 2007
- KLTO 2019
- Country
- RVYL United States
- KLTO United States
- Employees
- RVYL N/A
- KLTO N/A
- Industry
- RVYL Professional Services
- KLTO
- Sector
- RVYL Consumer Discretionary
- KLTO
- Exchange
- RVYL Nasdaq
- KLTO NYSE
- Market Cap
- RVYL 8.2M
- KLTO 7.1M
- IPO Year
- RVYL N/A
- KLTO N/A
- Fundamental
- Price
- RVYL $0.76
- KLTO $0.21
- Analyst Decision
- RVYL Hold
- KLTO
- Analyst Count
- RVYL 1
- KLTO 0
- Target Price
- RVYL N/A
- KLTO N/A
- AVG Volume (30 Days)
- RVYL 34.1M
- KLTO 35.4M
- Earning Date
- RVYL 05-20-2025
- KLTO 05-15-2025
- Dividend Yield
- RVYL N/A
- KLTO N/A
- EPS Growth
- RVYL N/A
- KLTO N/A
- EPS
- RVYL N/A
- KLTO N/A
- Revenue
- RVYL $54,357,000.00
- KLTO N/A
- Revenue This Year
- RVYL $27.50
- KLTO N/A
- Revenue Next Year
- RVYL $35.71
- KLTO N/A
- P/E Ratio
- RVYL N/A
- KLTO N/A
- Revenue Growth
- RVYL N/A
- KLTO N/A
- 52 Week Low
- RVYL $0.36
- KLTO $0.11
- 52 Week High
- RVYL $2.40
- KLTO $0.99
- Technical
- Relative Strength Index (RSI)
- RVYL 51.69
- KLTO N/A
- Support Level
- RVYL $0.36
- KLTO N/A
- Resistance Level
- RVYL $1.20
- KLTO N/A
- Average True Range (ATR)
- RVYL 0.26
- KLTO 0.00
- MACD
- RVYL 0.02
- KLTO 0.00
- Stochastic Oscillator
- RVYL 20.30
- KLTO 0.00
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.